BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Strickland GT, Elhefni H, Salman T, Waked I, Abdel-Hamid M, Mikhail NN, Esmat G, Fix A. Role of hepatitis C infection in chronic liver disease in Egypt. Am J Trop Med Hyg 2002;67:436-42. [PMID: 12452500 DOI: 10.4269/ajtmh.2002.67.436] [Cited by in Crossref: 84] [Cited by in F6Publishing: 81] [Article Influence: 4.2] [Reference Citation Analysis]
Number Citing Articles
1 Abdelaziz AO, Nabil MM, Omran DA, Abdelmaksoud AH, Asem N, Shousha HI, Elbaz TM, Leithy R. Hepatocellular Carcinoma Multidisciplinary Clinic-Cairo University (HMC-CU) score: A new simple score for diagnosis of HCC. Arab J Gastroenterol 2020;21:102-5. [PMID: 32439235 DOI: 10.1016/j.ajg.2020.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
2 Bakr NM, Awad A, A Moustafa E. Association of genetic variants in the interleukin-18 gene promoter with risk of hepatocellular carcinoma and metastasis in patients with hepatitis C virus infection. IUBMB Life 2018;70:165-74. [PMID: 29341496 DOI: 10.1002/iub.1714] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
3 Esmat G, Metwally M, Zalata KR, Gadalla S, Abdel-Hamid M, Abouzied A, Shaheen AA, El-Raziky M, Khatab H, El-Kafrawy S. Evaluation of serum biomarkers of fibrosis and injury in Egyptian patients with chronic hepatitis C. J Hepatol. 2007;46:620-627. [PMID: 17316875 DOI: 10.1016/j.jhep.2006.12.010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
4 Tanamly MD, Tadros F, Labeeb S, Makld H, Shehata M, Mikhail N, Abdel-Hamid M, Shehata M, Abu-Baki L, Medhat A. Randomised double-blinded trial evaluating silymarin for chronic hepatitis C in an Egyptian village: study description and 12-month results. Dig Liver Dis. 2004;36:752-759. [PMID: 15571006 DOI: 10.1016/j.dld.2004.06.015] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 2.7] [Reference Citation Analysis]
5 Kouyoumjian SP, Chemaitelly H, Abu-Raddad LJ. Characterizing hepatitis C virus epidemiology in Egypt: systematic reviews, meta-analyses, and meta-regressions. Sci Rep. 2018;8:1661. [PMID: 29374178 DOI: 10.1038/s41598-017-17936-4] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 17.3] [Reference Citation Analysis]
6 Zaki SR, Alves VA, Hale GL. Non-Hepatotropic Viral, Bacterial, and Parasitic Infections of the Liver. Macsween's Pathology of the Liver. Elsevier; 2018. pp. 416-90. [DOI: 10.1016/b978-0-7020-6697-9.00007-8] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Strickland GT, El-kamary SS, Klenerman P, Nicosia A. Hepatitis C vaccine: supply and demand. The Lancet Infectious Diseases 2008;8:379-86. [DOI: 10.1016/s1473-3099(08)70126-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 21] [Article Influence: 4.5] [Reference Citation Analysis]
8 Zaher T, Ibrahim I, Ibrahim A. Endoscopic band ligation of internal haemorrhoids versus stapled haemorrhoidopexy in patients with portal hypertension. Arab J Gastroenterol 2011;12:11-4. [PMID: 21429448 DOI: 10.1016/j.ajg.2011.01.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
9 El Garf A, Shaheen N, Gaber W, Sobhy N. Prevalence and impact of chronic hepatitis C virus infection on the clinical manifestations and disease activity among patients suffering from systemic lupus erythematosus. The Egyptian Rheumatologist 2013;35:9-14. [DOI: 10.1016/j.ejr.2012.09.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
10 Chaudhuri S, Das S, Chowdhury A, Santra A, Bhattacharya SK, Naik TN. Molecular epidemiology of HCV infection among acute and chronic liver disease patients in Kolkata, India. J Clin Virol. 2005;32:38-46. [PMID: 15572005 DOI: 10.1016/j.jcv.2004.07.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 27] [Article Influence: 1.2] [Reference Citation Analysis]
11 Allam WR, Barakat A, Zakaria Z, Galal G, Abdel-Ghafar TS, El-Tabbakh M, Mikhail N, Waked I, Abdelwahab SF. Schistosomiasis does not affect the outcome of HCV infection in genotype 4-infected patients. Am J Trop Med Hyg. 2014;90:823-829. [PMID: 24615138 DOI: 10.4269/ajtmh.13-0703] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
12 Khattab MA, Ferenci P, Hadziyannis SJ, Colombo M, Manns MP, Almasio PL, Esteban R, Abdo AA, Harrison SA, Ibrahim N, Cacoub P, Eslam M, Lee SS. Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel. Journal of Hepatology 2011;54:1250-62. [DOI: 10.1016/j.jhep.2010.11.016] [Cited by in Crossref: 86] [Cited by in F6Publishing: 84] [Article Influence: 7.8] [Reference Citation Analysis]
13 Mohamed AA, Amin MA, Ragab MM, Ismail SA, Baki AA. Protein kinase expression as a predictive factor for interferon response in chronic hepatitis C patients. J Adv Res 2014;5:117-23. [PMID: 25685478 DOI: 10.1016/j.jare.2013.01.002] [Reference Citation Analysis]
14 El-Zayadi AR, Attia M, Badran HM, El-Tawil A, Zalata K, Barakat E, Selim O, El-Nakeeb A, Saied A. Non-interferon-based therapy: an option for amelioration of necro-inflammation in hepatitis C patients who cannot afford interferon therapy. Liver Int 2005;25:746-51. [PMID: 15998425 DOI: 10.1111/j.1478-3231.2005.01110.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
15 El-Mesallamy HO, Hamdy NM, Rizk HH, El-Zayadi AR. Apelin serum level in Egyptian patients with chronic hepatitis C. Mediators Inflamm 2011;2011:703031. [PMID: 22007137 DOI: 10.1155/2011/703031] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
16 El-Akel W, El-Sayed MH, El Kassas M, El-Serafy M, Khairy M, Elsaeed K, Kabil K, Hassany M, Shawky A, Yosry A, Shaker MK, ElShazly Y, Waked I, Esmat G, Doss W. National treatment programme of hepatitis C in Egypt: Hepatitis C virus model of care. J Viral Hepat. 2017;24:262-267. [PMID: 28145032 DOI: 10.1111/jvh.12668] [Cited by in Crossref: 89] [Cited by in F6Publishing: 83] [Article Influence: 17.8] [Reference Citation Analysis]
17 Mohamed MK, Bakr I, El-Hoseiny M, Arafa N, Hassan A, Ismail S, Anwar M, Attala M, Rekacewicz C, Zalata K. HCV-related morbidity in a rural community of Egypt. J Med Virol. 2006;78:1185-1189. [PMID: 16847958 DOI: 10.1002/jmv.20679] [Cited by in Crossref: 29] [Cited by in F6Publishing: 32] [Article Influence: 1.8] [Reference Citation Analysis]
18 Omran MH, Khamis M, Nasr N, Massoud AA, Youssef SS, Bader El Din NG, Dawood RM, Atef K, Moustafa RI, Nabil W, Tabll AA, El Awady MK. A Study of CC-Chemokine Receptor 5 (CCR5) Polymorphism on the Outcome of HCV Therapy in Egyptian Patients. Hepat Mon 2013;13:e13721. [PMID: 24403912 DOI: 10.5812/hepatmon.13721] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
19 Ayad MW, Elbanna AA, Elneily DA, Sakr AS. Association of BAFF -871C/T Promoter Polymorphism with Hepatitis C-Related Mixed Cryoglobulinemia in a Cohort of Egyptian Patients. Mol Diagn Ther 2015;19:99-106. [PMID: 25800158 DOI: 10.1007/s40291-015-0134-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Seoud RAA, Mabrouk MS. TMT-HCC: A tool for text mining the biomedical literature for hepatocellular carcinoma (HCC) biomarkers identification. Computer Methods and Programs in Biomedicine 2013;112:640-8. [DOI: 10.1016/j.cmpb.2013.07.014] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
21 Pedergnana V, Abdel-Hamid M, Guergnon J, Mohsen A, Le Fouler L, Theodorou I, Mohamed MK, Fontanet A, Plancoulaine S, Abel L. Analysis of IL28B variants in an Egyptian population defines the 20 kilobases minimal region involved in spontaneous clearance of hepatitis C virus. PLoS One. 2012;7:e38578. [PMID: 22719902 DOI: 10.1371/journal.pone.0038578] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 2.7] [Reference Citation Analysis]
22 Fu LJ, Lü SL, Cheng XF, Wang XY. Alterations of HCV in peripheral blood mononuclear cells from IFN-treated patients with chronic HCV RNA infection. Shijie Huaren Xiaohua Zazhi 2004; 12(3): 610-613 [DOI: 10.11569/wcjd.v12.i3.610] [Reference Citation Analysis]
23 Agha S, El-Mashad N, El-Malky M, El-Shony H, El-Sherif MZ, El-Hasan MA, Tanaka Y, Mizokami M. Prevalence of low positive anti-HCV antibodies in blood donors: Schistosoma mansoni co-infection and possible role of autoantibodies. Microbiol Immunol 2006;50:447-52. [PMID: 16785716 DOI: 10.1111/j.1348-0421.2006.tb03813.x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.3] [Reference Citation Analysis]
24 Saleh O, Baiomy AA, El-desouky A, Zaghloul H, El-Arman M, Dahab GM, Abdel-Rahman MS. Hepatitis C virus genotype distribution in Egyptian diabetic patients: a preliminary study. Arab J Gastroenterol 2013;14:14-9. [PMID: 23622804 DOI: 10.1016/j.ajg.2013.01.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K. Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis. Transplant Proc 2008;40:1481-4. [PMID: 18589133 DOI: 10.1016/j.transproceed.2008.03.085] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
26 Attwa MH, El-Etreby SA. Guide for diagnosis and treatment of hepatocellular carcinoma. World J Hepatol 2015; 7(12): 1632-1651 [PMID: 26140083 DOI: 10.4254/wjh.v7.i12.1632] [Cited by in Crossref: 120] [Cited by in F6Publishing: 107] [Article Influence: 17.1] [Reference Citation Analysis]
27 Elbadri A, Esmat S, Abosaif N, Morsi A, Shaker O. Study of serum ghrelin changes and its correlation with malnutrition in liver cirrhosis in Egypt. Clinics and Research in Hepatology and Gastroenterology 2011;35:638-43. [DOI: 10.1016/j.clinre.2011.07.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
28 Elhendawy M, Abo-Ali L, Abd-Elsalam S, Hagras MM, Kabbash I, Mansour L, Atia S, Esmat G, Abo-ElAzm AR, El-Kalla F, Kobtan A. HCV and HEV: two players in an Egyptian village, a study of prevalence, incidence, and co-infection. Environ Sci Pollut Res Int 2020;27:33659-67. [PMID: 32533486 DOI: 10.1007/s11356-020-09591-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
29 Attallah AM, El-Far M, Omran MM, Farid K, Attallah AA, Abd-Elaziz D, El-Bendary MS, El-Dosoky I, Ismail H. Levels of Schistosoma mansoni Circulating Antigen in Chronic Hepatitis C Patients with Different Stages of Liver Fibrosis. J Immunoassay Immunochem 2016;37:316-30. [PMID: 26745203 DOI: 10.1080/15321819.2015.1135163] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
30 Lehman EM, Soliman AS, Ismail K, Hablas A, Seifeldin IA, Ramadan M, El-Hamzawy H, Shoushtari CS, Wilson ML. Patterns of hepatocellular carcinoma incidence in Egypt from a population-based cancer registry. Hepatol Res 2008;38:465-73. [PMID: 18042228 DOI: 10.1111/j.1872-034X.2007.00299.x] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
31 Strickland GT. Liver disease in Egypt: Hepatitis C superseded schistosomiasis as a result of iatrogenic and biological factors. Hepatology 2006;43:915-22. [DOI: 10.1002/hep.21173] [Cited by in Crossref: 161] [Cited by in F6Publishing: 136] [Article Influence: 10.1] [Reference Citation Analysis]
32 Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clin Liver Dis 2010;14:1-21, vii. [PMID: 20123436 DOI: 10.1016/j.cld.2009.11.009] [Cited by in Crossref: 276] [Cited by in F6Publishing: 239] [Article Influence: 23.0] [Reference Citation Analysis]
33 Elrefaei M, El-sheikh N, Kamal K, Cao H. Analysis of T cell responses against hepatitis C virus genotype 4 in Egypt. J Hepatol. 2004;40:313-318. [PMID: 14739104 DOI: 10.1016/j.jhep.2003.10.007] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 0.9] [Reference Citation Analysis]
34 Said F, El Beshlawy A, Hamdy M, El Raziky M, Sherif M, Abdel kader A, Ragab L. Intrafamilial transmission of hepatitis C infection in Egyptian multitransfused thalassemia patients. J Trop Pediatr 2013;59:309-13. [PMID: 23542535 DOI: 10.1093/tropej/fmt017] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
35 Fouad A, Sabry D, Ahmed R, Kamal M, Allah SA, Marzouk S, Amin M, Abd El Aziz R, El Badri A, Khattab H, Helmy D. Comparative diagnostic study of biomarkers using FibroMax™ and pathology for prediction of liver steatosis in patients with chronic hepatitis C virus infection: an Egyptian study. Int J Gen Med 2013;6:127-34. [PMID: 23662075 DOI: 10.2147/IJGM.S36433] [Reference Citation Analysis]
36 El-Zefzafy W, Eltokhy H, Mohamed NA, Abu-Zahab Z. Significance of Serum Cytokeratin-18 in Prediction of Hepatocellular Carcinoma in Chronic Hepatitis C Infected Egyptian Patients. Open Access Maced J Med Sci 2015;3:117-23. [PMID: 27275207 DOI: 10.3889/oamjms.2015.021] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
37 Bruguera M. [Liver diseases in the elderly]. Gastroenterol Hepatol. 2014;37:535-543. [PMID: 24951302 DOI: 10.1016/j.gastrohep.2014.04.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
38 Mohamoud YA, Mumtaz GR, Riome S, Miller D, Abu-Raddad LJ. The epidemiology of hepatitis C virus in Egypt: a systematic review and data synthesis. BMC Infect Dis. 2013;13:288. [PMID: 23799878 DOI: 10.1186/1471-2334-13-288] [Cited by in Crossref: 207] [Cited by in F6Publishing: 190] [Article Influence: 23.0] [Reference Citation Analysis]
39 Halim MH, Abdulla NA, Kamel A, El Maksoud NA, Ragab HM. Significance of growth differentiation factor 15 in chronic HCV patients. J Genet Eng Biotechnol. 2017;15:403-407. [PMID: 30647678 DOI: 10.1016/j.jgeb.2017.08.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
40 Mohran ZY, Ali-Eldin FA, Abdel Aal HA. Serum interleukin-18: does it have a role in the diagnosis of hepatitis C virus related hepatocellular carcinoma? Arab J Gastroenterol. 2011;12:29-33. [PMID: 21429452 DOI: 10.1016/j.ajg.2010.11.002] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.5] [Reference Citation Analysis]
41 Ahmed AM, Hassan MS, Abd-Elsayed A, Hassan H, Hasanain AF, Helmy A. Insulin resistance, steatosis, and fibrosis in Egyptian patients with chronic Hepatitis C virus infection. Saudi J Gastroenterol. 2011;17:245-251. [PMID: 21727730 DOI: 10.4103/1319-3767.82578] [Cited by in Crossref: 5] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
42 Abdelwahab SF, Zakaria Z, Sobhy M, Rewisha E, Mahmoud MA, Amer MA, Del Sorbo M, Capone S, Nicosia A, Folgori A. Hepatitis C virus-multispecific T-cell responses without viremia or seroconversion among Egyptian health care workers at high risk of infection. Clin Vaccine Immunol. 2012;19:780-786. [PMID: 22441392 DOI: 10.1128/cvi.00050-12] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
43 Mohamoud YA, Miller FD, Abu-Raddad LJ. Potential for human immunodeficiency virus parenteral transmission in the Middle East and North Africa: An analysis using hepatitis C virus as a proxy biomarker. World J Gastroenterol 2014; 20(36): 12734-12752 [PMID: 25278675 DOI: 10.3748/wjg.v20.i36.12734] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
44 Loffredo-Verde E, Abdel-Aziz I, Albrecht J, El-Guindy N, Yacob M, Solieman A, Protzer U, Busch DH, Layland LE, Prazeres da Costa CU. Schistosome infection aggravates HCV-related liver disease and induces changes in the regulatory T-cell phenotype. Parasite Immunol 2015;37:97-104. [PMID: 25559085 DOI: 10.1111/pim.12171] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
45 Hamdy S, Nye C. Comics and revolution as global public health intervention: The Case of Lissa. Glob Public Health 2019;:1-21. [PMID: 31640450 DOI: 10.1080/17441692.2019.1682632] [Reference Citation Analysis]
46 Esmat S, Omarn D, Rashid L. Can we consider the right hepatic lobe size/albumin ratio a noninvasive predictor of oesophageal varices in hepatitis C virus-related liver cirrhotic Egyptian patients? Eur J Intern Med. 2012;23:267-272. [PMID: 22385886 DOI: 10.1016/j.ejim.2011.11.010] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
47 Shabana MM, El Sayed AM, Yousif MF, El Sayed AM, Sleem AA. Bioactive constituents from Harpephyllum caffrum Bernh. and Rhus coriaria L. Pharmacogn Mag 2011;7:298-306. [PMID: 22262932 DOI: 10.4103/0973-1296.90410] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
48 El-Ghitany EM, Abdel Wahab MM, Abd El-Wahab EW, Hassouna S, Farghaly AG. A comprehensive hepatitis C virus risk factors meta-analysis (1989-2013): do they differ in Egypt? Liver Int. 2015;35:489-501. [PMID: 24923487 DOI: 10.1111/liv.12617] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
49 Omran DA, Behairy NH, Zakaria KS, Nabil MM, Said K. Functional and morphological myocardial changes in hepatitis C virus patients with end-stage liver disease. Scand J Gastroenterol. 2015;50:1135-1143. [PMID: 25716364 DOI: 10.3109/00365521.2015.1019559] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
50 Shiha G, Seif S, Maher M, Etreby S, Samir W, Zalata K. Comparison between transient elastography (Fibroscan) and liver biopsy for the diagnosis of hepatic fibrosis in chronic hepatitis C genotype 4: . Egyptian Liver Journal 2014;4:106-11. [DOI: 10.1097/01.elx.0000454686.81811.1a] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
51 Mahmud S, Kouyoumjian SP, Al Kanaani Z, Chemaitelly H, Abu-Raddad LJ. Individual-level key associations and modes of exposure for hepatitis C virus infection in the Middle East and North Africa: a systematic synthesis. Ann Epidemiol 2018;28:452-61. [PMID: 29661680 DOI: 10.1016/j.annepidem.2018.03.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
52 Zakaria S, Youssef M, Moussa M, Akl M, El-Ahwany E, El-Raziky M, Mostafa O, Helmy AH, El-Hindawi A. Value of α-smooth muscle actin and glial fibrillary acidic protein in predicting early hepatic fibrosis in chronic hepatitis C virus infection. Arch Med Sci 2010;6:356-65. [PMID: 22371771 DOI: 10.5114/aoms.2010.14255] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 0.8] [Reference Citation Analysis]
53 Abdelwahab SF, Zakaria Z, Sobhy M, Hamdy S, Mahmoud MA, Mikhail N, Allam WR, Rewisha E, Waked I. Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response. Arch Virol 2015;160:1741-50. [PMID: 25971683 DOI: 10.1007/s00705-015-2446-7] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
54 El Garf A, El Zorkany B, Gheith R, Sheba H, Abdel Moneim G, El Garf K. Prevalence and clinical presentations of hepatitis C virus among patients admitted to the rheumatology ward. Rheumatol Int 2012;32:2691-5. [DOI: 10.1007/s00296-011-2014-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]
55 Abruzzi A, Fried B, Alikhan SB. Coinfection of Schistosoma Species with Hepatitis B or Hepatitis C Viruses. Adv Parasitol 2016;91:111-231. [PMID: 27015949 DOI: 10.1016/bs.apar.2015.12.003] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
56 Said M. Evaluation of routine biochemical indices and α-fetoprotein versus histology in chronic hepatitis C patients. Arab Journal of Gastroenterology 2009;10:87-91. [DOI: 10.1016/j.ajg.2009.08.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
57 Mikhail NN, Lewis DL, Omar N, Taha H, El-badawy A, Abdel-mawgoud N, Abdel-hamid M, Strickland GT. Prospective study of cross-infection from upper-GI endoscopy in a hepatitis C–prevalent population. Gastrointestinal Endoscopy 2007;65:584-8. [DOI: 10.1016/j.gie.2006.07.033] [Cited by in Crossref: 24] [Cited by in F6Publishing: 17] [Article Influence: 1.6] [Reference Citation Analysis]
58 Hassan EM, Omran DA, El Beshlawey ML, Abdo M, El Askary A. Can transient elastography, Fib-4, Forns Index, and Lok Score predict esophageal varices in HCV-related cirrhotic patients? Gastroenterol Hepatol. 2014;37:58-65. [PMID: 24365388 DOI: 10.1016/j.gastrohep.2013.09.008] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.9] [Reference Citation Analysis]
59 El Sayed ZM, Mansour FA, Ghal MF, Abou-Zahra SB. Evaluation of interleukin-8 in hepatitis C virus infection: relation to combined peg-interferon ribavirin response and genotype 4. Immunol Invest 2011;40:29-38. [PMID: 20809700 DOI: 10.3109/08820139.2010.508192] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
60 Lucas SB, Zaki SR, Portmann BC. Other viral and infectious diseases and HIV-related liver disease. MacSween's Pathology of the Liver. Elsevier; 2012. pp. 403-66. [DOI: 10.1016/b978-0-7020-3398-8.00008-8] [Cited by in Crossref: 5] [Article Influence: 0.5] [Reference Citation Analysis]
61 Abdelwahab S, Rewisha E, Hashem M, Sobhy M, Galal I, Allam WR, Mikhail N, Galal G, El-Tabbakh M, El-Kamary SS, Waked I, Strickland GT. Risk factors for hepatitis C virus infection among Egyptian healthcare workers in a national liver diseases referral centre. Trans R Soc Trop Med Hyg 2012;106:98-103. [PMID: 22197011 DOI: 10.1016/j.trstmh.2011.10.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 2.7] [Reference Citation Analysis]
62 Esmat G, Fattah SA. Evaluation of a novel pegylated interferon alpha-2a (Reiferon Retard®) in Egyptian patients with chronic hepatitis C – genotype 4. Digestive and Liver Disease Supplements 2009;3:17-9. [DOI: 10.1016/s1594-5804(09)60011-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
63 Abdel-hamid M, El-daly M, Molnegren V, El-kafrawy S, Abdel-latif S, Esmat G, Strickland GT, Loffredo C, Albert J, Widell A. Genetic diversity in hepatitis C virus in Egypt and possible association with hepatocellular carcinoma. Journal of General Virology 2007;88:1526-31. [DOI: 10.1099/vir.0.82626-0] [Cited by in Crossref: 92] [Cited by in F6Publishing: 91] [Article Influence: 6.1] [Reference Citation Analysis]
64 Ebeid Mel-S, El-Bakry KA. Cellular immune response to infection by different genotypes of hepatitis C virus. Indian J Clin Biochem 2009;24:234-40. [PMID: 23105841 DOI: 10.1007/s12291-009-0044-8] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
65 El-Zorkany B, Mokbel A, Gamal SM, Mousa M, Youssef M, Hmamouchi I. Comparison of comorbidities of the Egyptian rheumatoid arthritis patients to the global cohort of the COMORA study: a post-hoc analysis. Clin Rheumatol 2016;35:1153-9. [PMID: 26670453 DOI: 10.1007/s10067-015-3142-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
66 Mohamed HI, Saad ZM, Abd-Elreheem EM, Abd-ElGhany WM, Mohamed MS, Abd Elnaeem EA, Seedhom AE. Hepatitis C, hepatitis B and HIV infection among Egyptian prisoners: seroprevalence, risk factors and related chronic liver diseases. J Infect Public Health. 2013;6:186-195. [PMID: 23668463 DOI: 10.1016/j.jiph.2012.12.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 21] [Article Influence: 2.0] [Reference Citation Analysis]
67 Aguilar CE, Soliman AS, McConnell DS, Zekri AR, Banerjee M, Omar A, Sharawy M, Omar S, Raouf A, Sowers MR. Androgen profiles among Egyptian adults considering liver status. J Gastroenterol Hepatol. 2008;23:e137-e145. [PMID: 17524040 DOI: 10.1111/j.1440-1746.2007.04949.x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
68 Silva JL, de Souza VS, Vilella TA, Domingues AL, Coêlho MR. HBV and HCV serological markers in patients with the hepatosplenic form of mansonic schistosomiasis. Arq Gastroenterol 2011;48:124-30. [PMID: 21709954 DOI: 10.1590/s0004-28032011000200008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
69 Esmat S, Elgendy D, Ali M, Esmat S, El-Nabarawy EA, Mahmoud SB, Shaker O. Prevalence of photosensitivity in chronic hepatitis C virus patients and its relation to serum and urinary porphyrins. Liver Int 2014;34:1033-9. [PMID: 24575939 DOI: 10.1111/liv.12513] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
70 Poggio PD, Mazzoleni M. Screening in liver disease. World J Gastroenterol 2006; 12(33): 5272-5280 [PMID: 16981254 DOI: 10.3748/wjg.v12.i33.5272] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
71 Abd El Moety HA, Maharem DA, Gomaa SH. Serotonin: is it a marker for the diagnosis of hepatocellular carcinoma in cirrhotic patients? Alexandria Journal of Medicine 2013;49:369-78. [DOI: 10.1016/j.ajme.2013.03.010] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
72 Barsoum R. The changing face of schistosomal glomerulopathy. Kidney Int 2004;66:2472-84. [PMID: 15569345 DOI: 10.1111/j.1523-1755.2004.66042.x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 20] [Article Influence: 1.9] [Reference Citation Analysis]
73 Lehman EM, Wilson ML. Epidemiology of hepatitis viruses among hepatocellular carcinoma cases and healthy people in Egypt: a systematic review and meta-analysis. Int J Cancer. 2009;124:690-697. [PMID: 18973270 DOI: 10.1002/ijc.23937] [Cited by in Crossref: 86] [Cited by in F6Publishing: 76] [Article Influence: 6.1] [Reference Citation Analysis]
74 Ayoub HH, Chemaitelly H, Kouyoumjian SP, Abu-Raddad LJ. Characterizing the historical role of parenteral antischistosomal therapy in hepatitis C virus transmission in Egypt. Int J Epidemiol 2020;49:798-809. [PMID: 32357208 DOI: 10.1093/ije/dyaa052] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
75 Sievert W, Altraif I, Razavi HA, Abdo A, Ahmed EA, Alomair A, Amarapurkar D, Chen CH, Dou X, El Khayat H. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt. Liver Int. 2011;31 Suppl 2:61-80. [PMID: 21651703 DOI: 10.1111/j.1478-3231.2011.02540.x] [Cited by in Crossref: 364] [Cited by in F6Publishing: 344] [Article Influence: 33.1] [Reference Citation Analysis]
76 Afify S, Eysa B, Hamid FA, Abo-Elazm OM, Edris MA, Maher R, Abdelhalim A, Abdel Ghaffar MM, Omran DA, Shousha HI. Survival and outcomes for co-infection of chronic hepatitis C with and without cirrhosis and COVID-19: A multicenter retrospective study. World J Gastroenterol 2021; 27(42): 7362-7375 [PMID: 34876795 DOI: 10.3748/wjg.v27.i42.7362] [Reference Citation Analysis]
77 El-Zayadi AR, Attia M, Barakat EM, Badran HM, Hamdy H, El-Tawil A, El-Nakeeb A, Selim O, Saied A. Response of hepatitis C genotype-4 naïve patients to 24 weeks of Peg-interferon-alpha2b/ribavirin or induction-dose interferon-alpha2b/ribavirin/amantadine: a non-randomized controlled study. Am J Gastroenterol. 2005;100:2447-2452. [PMID: 16279899 DOI: 10.1111/j.1572-0241.2005.00253.x] [Cited by in Crossref: 53] [Cited by in F6Publishing: 51] [Article Influence: 3.1] [Reference Citation Analysis]
78 Farid A, Al-Sherbiny M, Osman A, Mohamed N, Saad A, Shata MT, Lee DH, Prince AM, Strickland GT. Schistosoma infection inhibits cellular immune responses to core HCV peptides. Parasite Immunol 2005;27:189-96. [PMID: 15987342 DOI: 10.1111/j.1365-3024.2005.00762.x] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 2.1] [Reference Citation Analysis]
79 Hamdy SF. Political challenges to biomedical universalism: kidney failure among Egypt's poor. Med Anthropol 2013;32:374-92. [PMID: 23768221 DOI: 10.1080/01459740.2013.778255] [Cited by in Crossref: 8] [Article Influence: 0.9] [Reference Citation Analysis]
80 Waked I, Doss W, El-sayed MH, Estes C, Razavi H, Shiha G, Yosry A, Esmat G. The current and future disease burden of chronic hepatitis C virus infection in Egypt. Arab Journal of Gastroenterology 2014;15:45-52. [DOI: 10.1016/j.ajg.2014.04.003] [Cited by in Crossref: 56] [Cited by in F6Publishing: 50] [Article Influence: 7.0] [Reference Citation Analysis]
81 Van-Lume DS, Albuquerque Mde F, Souza AI, Domingues AL, Lopes EP, Morais CN, Montenegro SM. Association between Schistosomiasis mansoni and hepatitis C: systematic review. Rev Saude Publica. 2013;47:414-424. [PMID: 24037369 DOI: 10.1590/s0034-910.2013047004247] [Cited by in Crossref: 18] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
82 Deuffic-Burban S, Mohamed MK, Larouze B, Carrat F, Valleron AJ. Expected increase in hepatitis C-related mortality in Egypt due to pre-2000 infections. J Hepatol. 2006;44:455-461. [PMID: 16310281 DOI: 10.1016/j.jhep.2005.08.008] [Cited by in Crossref: 60] [Cited by in F6Publishing: 53] [Article Influence: 3.5] [Reference Citation Analysis]
83 Harfouche M, Chemaitelly H, Kouyoumjian SP, Mahmud S, Chaabna K, Al-Kanaani Z, Abu-Raddad LJ. Hepatitis C virus viremic rate in the Middle East and North Africa: Systematic synthesis, meta-analyses, and meta-regressions. PLoS One. 2017;12:e0187177. [PMID: 29088252 DOI: 10.1371/journal.pone.0187177] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
84 Ryu SH, Fan X, Xu Y, Elbaz T, Zekri AN, Abdelaziz AO, Di Bisceglie AM. Lack of association between genotypes and subtypes of HCV and occurrence of hepatocellular carcinoma in Egypt. J Med Virol 2009;81:844-7. [DOI: 10.1002/jmv.21451] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.9] [Reference Citation Analysis]
85 Abdelwahab SF, Hashem M, Galal I, Sobhy M, Abdel-ghaffar TS, Galal G, Mikhail N, El-kamary SS, Waked I, Strickland GT. Incidence of hepatitis C virus infection among Egyptian healthcare workers at high risk of infection. Journal of Clinical Virology 2013;57:24-8. [DOI: 10.1016/j.jcv.2013.01.005] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]